Bayer

Congressional Reps Question Gottlieb on Bayer's Follow-Up Essure Studies
RAPS.org
Tue, 10/31/17 - 09:15 pm
US Congress
FDA
Scott Gottlieb
Bayer
Essure
What’s driving the rapid growth of the top 20 biopharma companies in the world?
Endpoints
Wed, 10/25/17 - 11:24 am
JNJ
Roche
Pfizer
Novartis
Merck
Serono
AbbVie
Sanofi
Amgen
Bayer
GSK
Big trial failure for Xarelto in clot prevention won’t affect sales, Bayer vows
Fierce Pharma
Sun, 10/8/17 - 10:15 am
Bayer
Xarelto
bloodthinners
In a setback, Bayer, J&J say their big PhIII secondary stroke trial for Xarelto failed
Endpoints
Fri, 10/6/17 - 09:47 am
Bayer
JNJ
stroke
clinical trials
Xarelto
bloodthinners
Bristol-Myers' I-O star Opdivo steps up to challenge Bayer's Stivarga in liver cancer
Fierce Pharma
Mon, 09/25/17 - 11:04 am
Bristol-Myers Squibb
Opdivo
Bayer
Stivarga
liver cancer
Bayer halts sales of Essure outside US
Mass Device
Tue, 09/19/17 - 10:16 pm
Bayer
Essure
contraceptives
devices
Bayer gears up to take on Gilead in lymphoma with Aliqopa green light
Fierce Pharma
Sat, 09/16/17 - 11:58 am
Bayer
Gilead Sciences
Aliqopa
copanlisib
relapsed follicular lymphoma
Bayer boosted as FDA OKs its PI3K drug Aliqopa for relapsed follicular lymphoma patients
Endpoints
Fri, 09/15/17 - 09:51 am
Bayer
FDA
Aliqopa
relapsed follicular lymphoma
Hemo-oncology newbie Bayer gears up for copanlisib launch
Fierce Pharma
Wed, 09/13/17 - 10:37 am
hemo-oncology
Bayer
drug launches
copanlisib
lymphoma
Bayer files longer-acting bleeding candidate to FDA
Fierce Biotech
Fri, 09/1/17 - 10:15 am
Bayer
FDA
BAY94-9027
hemophilia A
ESC 2017 – Bleeding blunts Xarelto’s Compass victory
EP Vantage
Sun, 08/27/17 - 05:48 pm
European Society of Cardiology
Xarelto
bloodthinners
Bayer
J&J
Pharma Stocks That Could Move On New Data
Barron's
Sat, 08/26/17 - 07:36 pm
pharma stocks
AbbVie
Bayer
Novartis
Bristol-Myers Squibb
Eli Lilly
European Society of Cardiology
Bayer, J&J win third U.S. trial over Xarelto bleeding risk
Yahoo/Reuters
Sat, 08/19/17 - 10:32 am
Bayer
JNJ
Xarelto
bloodthinners
Lawmakers dig into 'skyrocketing' MS costs with probe into 7 drugmakers
Fierce Pharma
Thu, 08/17/17 - 11:48 pm
multiple sclerosis
MS
drug pricing
Bayer
Biogen
Merck KGaA
Novartis
Sanofi
Teva Pharmaceutical
Roche
The 2017 report card so far: Big Biotech largely trading up as pharma posts mixed results
Fierce Pharma
Thu, 08/10/17 - 06:58 pm
pharma stocks
Merck
Pfizer
AbbVie
Eli Lilly
Bristol-Myers Squibb
GSK
Roche
Sanofi
Bayer
Novo Nordisk
Celgene
Biogen
AstraZeneca
Bayer drops checkpoint regulator from Compugen pact
Fierce Biotech
Wed, 07/26/17 - 10:05 am
Bayer
CompuGen
CGEN-15022
immune checkpoint regulators
Why ImmunoGen, Inc. Jumped Higher Today
Motley Fool
Tue, 07/25/17 - 12:01 am
Immunogen
anetumab ravtansine
Bayer
mesothelioma
Bayer misses in mesothelioma Phase 2
BioPharma Dive
Mon, 07/24/17 - 11:05 am
Bayer
mesothelioma
clinical trials
anetumab ravtansine
Bayer’s blockbuster pipeline promises broken by a PhII setback for top cancer drug
Endpoints
Fri, 07/21/17 - 03:12 pm
Bayer
clinical trials
anetumab ravtansine
mesothelioma
Missouri judge slashes 86 plaintiffs from Essure suit against Bayer
Mass Device
Mon, 07/17/17 - 06:48 pm
Missouri
Essure
Bayer
devices
contraceptives

Pages